Mechanisms of Closed-loop SCS
Date: October 21, 2021
Time: 05:30PM - 06:30PM
You must be registered to participate!
Mechanisms of Closed-loop SCS:
5 Years of Patient Data
Join Drs. Eric J. Grigsby, John Parker, and Lawrence Poree for a conversation on closed-loop spinal cord stimulation (SCS).
- What are evoked compound action potentials (ECAPs)?
- How are they used to create a closed-loop neuromodulation system?
- What can continuous monitoring the neural responses tell us about the presence and influence of pharmacological agents?
This nonaccredited educational webinar is provided for information only.
- Brooker, C., Russo, M., Cousins, M. J., Taylor, N., Holford, L., Martin, R., ... & Parker, J. (2021). ECAP‐Controlled Closed‐Loop Spinal Cord Stimulation Efficacy and Opioid Reduction Over 24‐Months: Final Results of the Prospective, Multicenter, Open‐Label Avalon Study. Pain Practice.
- Heijmans, L., & Joosten, E. A. (2020). Mechanisms and mode of action of spinal cord stimulation in chronic neuropathic pain. Postgraduate medicine, 132(sup3), 17-21.
- Parker, J., Karantonis, D., & Single, P. (2020). Hypothesis for the mechanism of action of ECAP-controlled closed-loop systems for spinal cord stimulation. Healthcare Technology Letters, 7(3), 76-80.
Dr. Lawrence Poree, MD, PhD. MPH, Clinical Professor, Department of Anesthesia, University of California at San Francisco (UCSF)
Dr. Eric J. Grigsby, MD, MBA, Founder & CEO, Neurovations: A Patient Care and Innovation Company
John Parker, PhD, Founder and Chief Science Officer, Saluda Medical